Key result
Copper chloride exhibited dose-dependent antiviral effects against feline calicivirus in F81 cells with an IC50 of 5.1 µM, and demonstrated synergy when combined with ribavirin.
Why the study?
Existing vaccines cannot provide complete protection against feline calicivirus due to substantial genetic variability, prompting research into antiviral drugs.
Does copper chloride reduce feline calicivirus replication in F81 cells?
Does copper chloride reduce feline calicivirus replication in F81 cells?
Copper chloride exhibits dose-dependent antiviral activity against feline calicivirus in vitro and acts synergistically with ribavirin, offering a potential candidate for FCV treatment.
Answers are grounded in this paper and cite their sources.
Supports copper-based antivirals in cell models; leaves open clinical translation pending in vivo studies.
Background: Feline calicivirus (FCV) is a common pathogen causing widely prevalent upper respiratory disease for kitten and felines in recent years. Due to the substantial genetic variability of the viral genes, existing vaccines cannot provide complete protection. Therefore, researches on FCV antiviral drugs have received much attention. Results: In this study, we found that copper chloride had dose-dependent antiviral effects against FCV in F81 cells. We also found that the combination of copper chloride and ribavirin had a synergistic effect against FCV in the F81 cells. In contrast, the combination of and horse anti-FCV immunoglobulin F(ab’) 2 showed an antagonistic effect, likely because the copper chloride has an effect on the F(ab’) 2 immunoglobulin; however, further research is needed to clarify this supposition. Conclusions: In summary, we found that copper chloride had low cytotoxicity and significant antiviral effects against FCV in F81 cells, providing a new drug candidate for the prevention and treatment of FCV infection.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied Feline calicivirus (FCV) infection. Copper chloride vs. Mock treatment (0.4% DMSO) was evaluated on Virus titre and relative RNA levels of FCV (IC50 5.1 µM, p=<0.001). Copper chloride exhibited dose-dependent antiviral effects against feline calicivirus in F81 cells with an IC50 of 5.1 µM, and demonstrated synergy when combined with ribavirin.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: